| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 07/27/1994 | EP0607774A2 Use of leflunomid for the inhibition of interleukin 1 alpha |
| 07/27/1994 | EP0607439A1 Nitrogenous heterocyclic compound |
| 07/27/1994 | EP0607413A1 Side chain derivatized 15-oxygenated sterols, methods of using them and a process for preparing them |
| 07/27/1994 | EP0607353A1 Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein |
| 07/27/1994 | EP0607346A1 Collagen constructs |
| 07/27/1994 | EP0607344A1 3,4-dihydro-4-oxo-3-(prop-2-enyl)-1-phtalazineacetic acids and derivatives, preparations thereof and drugs containing same |
| 07/27/1994 | EP0607325A1 PARATHYROID HORMONE ANALOGUES SUBSTITUTED AT aa?25,26,27 AND USE IN OSTEOPOROSIS TREATMENT |
| 07/27/1994 | EP0607233A1 3,9-diazabicyclo(3.3.1)nonane derivatives with 5-ht3 receptor antagonist activity |
| 07/27/1994 | EP0607178A1 Methods for the selection, separation and fusion of cells |
| 07/27/1994 | EP0607124A1 Alteration of rate and character of hair growth. |
| 07/27/1994 | EP0607122A1 Veterinary treatment |
| 07/27/1994 | CN1089947A 新的杂环化合物 New heterocyclic compounds |
| 07/27/1994 | CN1089946A Pharmaceuticals |
| 07/27/1994 | CA2114047A1 Internal radiation damage |
| 07/26/1994 | US5332831 Angiotensin antagonist |
| 07/26/1994 | US5332804 High molecular weight human angiogenic basic fibroblast growth factors |
| 07/26/1994 | US5332757 Enzyme inhibitors |
| 07/26/1994 | US5332755 Indole derivatives, a process for their preparation and their use in medicaments |
| 07/26/1994 | US5332727 Stable, ingestable and absorbable NADH and NADPH therapeutic compositions |
| 07/26/1994 | CA1331001C Naphthalenepropionic acid derivatives as anti-inflammatory/antiallergic agents |
| 07/26/1994 | CA1330995C (acyloxyalkyl)carbamates as bioreversible latentiating groups |
| 07/26/1994 | CA1330944C Pentacyclic triterpenoid compounds as topoisomerase inhibitors or cell differentiation inducers |
| 07/26/1994 | CA1330873C Inclination measuring device and a capsule therefor |
| 07/21/1994 | WO1994016070A1 Leukocyte derived growth factors |
| 07/21/1994 | WO1994016069A2 Ras associated gap proteins |
| 07/21/1994 | WO1994015966A1 Growth differentiation factor-9 |
| 07/21/1994 | WO1994015958A2 Peptide inhibitors of cell adhesion |
| 07/21/1994 | WO1994015955A1 Thiazolidine derivatives, preparation thereof and drugs containing same |
| 07/21/1994 | WO1994015954A1 Pyrrolidine and thiazolidine derivatives, their preparation and drugs containing same |
| 07/21/1994 | WO1994015949A1 Growth differentiation factor-5 |
| 07/21/1994 | WO1994015934A1 Quinoline-3-acetic acid derivative, process for producing the same, and use thereof |
| 07/21/1994 | WO1994015932A1 Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents |
| 07/21/1994 | WO1994015928A1 Piperazine derivatives as 5-ht antagonists |
| 07/21/1994 | WO1994015925A1 Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 07/21/1994 | WO1994015922A1 Novel process for preparing chiral [[(2-bromoethyl)amino]methyl]-2-nitro-1h-imidazol-1-ethanol and related compounds |
| 07/21/1994 | WO1994015919A1 Piperazine derivatives |
| 07/21/1994 | WO1994015916A1 Selective ligands of receptors 5-ht1d-5ht1b derived from indole-piperazine useful as medicaments |
| 07/21/1994 | WO1994015902A1 Compounds having selectivity for retinoid x receptors |
| 07/21/1994 | WO1994015900A1 Anti-androgenic cyclo and bicyclo alkenes |
| 07/21/1994 | WO1994015653A1 Tgf-beta formulation for inducing bone growth |
| 07/21/1994 | WO1994015641A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof |
| 07/21/1994 | WO1994015629A1 Method for treating myofascial pain syndrome |
| 07/21/1994 | WO1994015627A1 Methods for promoting cartilage matrix formation |
| 07/21/1994 | WO1994015613A1 Use of cyclooxygenase inhibitors for the manufacture of a medicament for enhancing uterine blood perfusion |
| 07/21/1994 | WO1994015606A1 Olefin-substituted long chain compounds |
| 07/21/1994 | WO1994015600A1 Application of riluzole as a radiorestorer |
| 07/21/1994 | WO1994015598A2 Methods for the improvement of cognition with functional antagonists of the glycine nmda receptor complex |
| 07/21/1994 | WO1994015592A1 Compositions comprising cholesterol lowering agents and antioxidants |
| 07/21/1994 | WO1994012639A3 Interleukin-3 (il-3) mutant polypeptides |
| 07/21/1994 | CA2297592A1 Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents |
| 07/21/1994 | CA2293952A1 Preparation of esters and analogs thereof |
| 07/21/1994 | CA2153781A1 Method for treating myofascial pain syndrome |
| 07/21/1994 | CA2153776A1 Method for modulating transendothelial migration of cells promoting inflammation, and related methods of measurement thereof |
| 07/21/1994 | CA2153698A1 Olefin-substituted long chain compounds |
| 07/21/1994 | CA2153654A1 Growth differentiation factor-5 |
| 07/21/1994 | CA2153596A1 Methods for the improvement of cognition with functional antagonists of the glycine nmda receptor complex |
| 07/21/1994 | CA2153486A1 Ras associated gap proteins |
| 07/21/1994 | CA2153409A1 Leukocyte derived growth factors |
| 07/21/1994 | CA2153241A1 Methods for promoting cartilage matrix formation |
| 07/21/1994 | CA2153228A1 Peptide inhibitors of cell adhesion |
| 07/21/1994 | CA2152184A1 Thiazolidine derivatives; process for preparing the same and drugs containing them |
| 07/21/1994 | CA2152183A1 Pyrrolidine and thiazolidine derivatives; process for preparing the same and drugs containing them |
| 07/21/1994 | CA2151486A1 Tgf-beta formulation for inducing bone growth |
| 07/21/1994 | CA2151262A1 Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
| 07/21/1994 | CA2136328A1 Novel process for preparing chiral [[(2-bromoethyl)amino] methyl]-2-nitro-1h-imidazol-1-ethanol and related compounds |
| 07/21/1994 | CA2131370A1 Quinoline-3-acetic acid derivative, process for production thereof and use thereof |
| 07/20/1994 | EP0607077A1 Salts of 4-pyrimidinone derivatives, their preparation and their application in therapy |
| 07/20/1994 | EP0607076A1 9H-Imidazo 1,2-a benzimidazole derivatives with GABA activity |
| 07/20/1994 | EP0606869A1 Promotor sequence of the p55 tumor necrosis factor receptor |
| 07/20/1994 | EP0606742A1 Bile acid sequestrant |
| 07/20/1994 | EP0606463A1 Neuromedin b receptor antagonists |
| 07/20/1994 | EP0606366A1 Substituted phenserines and phenylcarbamates of (-)-eseroline, (-)-n1-noreseroline, and (-)-n1-benzylnoreseroline; as specific inhibitors of acetylcholinesterase |
| 07/20/1994 | EP0606222A1 Cyclic hexapeptides as tachyquinin antagonists, their preparation and pharmaceutical compositions thereof |
| 07/20/1994 | EP0362283B1 Bovine interleukin-1 alpha |
| 07/20/1994 | CN1089660A Method for identifying individuals suffering from a cellular abnormality some of whose abnormal cells present complexes of human leukocyte antigen tyrosinase derived peptides, and methods for......... |
| 07/20/1994 | CN1089608A Imidazopyridines |
| 07/20/1994 | CN1089505A Novel pharmaceutical application of nonimmunogenproteinic material and composition |
| 07/20/1994 | CA2113580A1 Organic compounds |
| 07/19/1994 | US5331014 Effect of N,N,N-trimethylsphingosine on protein kinase-C activity; melanoma cell growth in vitro; metastatic potential in vivo and human platelet aggregation |
| 07/19/1994 | US5331009 Pharmaceutical compositions for treating adrenoleukodystrophy |
| 07/19/1994 | US5331008 Thioester enantiomeric compounds and their therapeutic uses |
| 07/19/1994 | US5330990 Substituted urea compounds and their preparation and use |
| 07/19/1994 | US5330985 2-amino-N-[[4-(aminocarbonyl)pyrimidin-2-yl]amino]-alkyl]pyrimidine-4-carboxamide derivatives, their preparation and pharmaceutical compositions containing them |
| 07/19/1994 | US5330977 Di-N-acetyl lysoganglioside compositions |
| 07/19/1994 | US5330895 Detection reagent and antibody specific for dopamine releasing protein |
| 07/19/1994 | US5330757 Method for the prevention and reversal of the extrinsic aging of the skin by transdermal application of selenamino acids and compositions therefore |
| 07/16/1994 | CA2113491A1 Salts of 4-pyrimidinone derivatives, their preparation and their therapeutic application |
| 07/16/1994 | CA2113490A1 9h-imidazo[1,2-a]benzimidazole-3-acetamide derivatives, their preparation and their therapeutic application |
| 07/13/1994 | EP0606049A1 Aminoalkylphenyl compounds |
| 07/13/1994 | EP0606046A1 Arylsulfonamido-substituted hydroxamic acids |
| 07/13/1994 | EP0605682A1 Peptidyl derivatives and their use as metalloproteinases inhibitors |
| 07/13/1994 | EP0605681A1 Sulphamide derivatives as metalloproteinase inhibitors |
| 07/13/1994 | EP0605639A1 Air treatment plant for foodstuff comprising a trough with an adjustable width. |
| 07/13/1994 | EP0605589A1 Pharmaceutical compositions comprising natriuretic peptides or neutral endopeptidase inhibitors for treating or preventing myointimal proliferation |
| 07/13/1994 | EP0605474A1 Carbamate analogs of thiaphysovenine, pharmaceutical compositions, and method for inhibiting cholinesterases |
| 07/13/1994 | EP0559751A4 Treatment for osteoporosis using growth hormone release factor (grf) in combination with parathyroid hormone (pth) |
| 07/13/1994 | EP0327640B1 Immunotherapeutic compositions for the treatment of acquired immune deficiency syndrome |
| 07/13/1994 | CN1089267A Chemical compounds |
| 07/13/1994 | CN1089265A Process for the preparation of imidazopyridines |
| 07/13/1994 | CN1089263A The sulphate salt of a substituted triazole, pharmaceutical compositions thereof, and their use in therapy |